Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • News
    • Dentistry
    • Breakthrough treatment...

    Breakthrough treatment for crippling jaw defect created

    Written by Vinay Singh singh Published On 2018-06-22T19:15:49+05:30  |  Updated On 27 May 2022 11:58 AM IST
    Breakthrough treatment for crippling jaw defect created

    In a major breakthrough, UC led researchers have successfully tested the first-ever tissue implant to safely treat a common jaw defect model, known as temporomandibular joint dysfunction in a large animal model, according to the recent findings published in the journal Science Translational Medicine.


    The temporomandibular joint (TMJ), or jaw joint, is a synovial articulation essential for daily functions such as talking and chewing. TMJ dysfunction causes pain and disability in 20 to 25% of adults worldwide.


    "We were able to show that we could achieve exceptional healing of the TMJ area after eight weeks of treatment," said biomedical engineering professor Kyriacos Athanasiou and senior author on the study.


    Kyriacos Athanasiou and his associates initiated the study to use a tissue engineering strategy to address disc thinning before irreversible degenerative changes of the articulating surfaces occur. The approach attempts to reconstruct damaged discs by repairing and strengthening the existing disc through fibrocartilaginous healing. By preserving joint anatomy, this approach has the potential to reduce degenerative changes at the early stages of injury or pathology, thereby preventing disease progression.


    Salient features:



    Tissue-engineered implants are durable after implantation

    The tissue-engineered implants were evaluated at 2 and 8 weeks after implantation. With the intralaminar fenestration technique, the implants remained in place and did not dislodge. The implants retained their shape and size, were partially fused with the surrounding native tissue at 2 weeks and were completely fused at 8 weeks. There was no evidence of implant breakage or fragmentation. These observations, collectively, indicated that the implants were sufficiently robust to withstand forces in the orthotopic environment.



    Allogeneic tissue-engineered implants are safe and tolerated immunologically

    CD68 (macrophage) immunoreactivity was rare to nonexistent around or within the implants. Furthermore, there was no histological evidence of multinucleated giant cells, polymorphonuclear cells (neutrophils and eosinophils), or capsule formation around the implants, indicating that the implants were tolerated immunologically and did not provoke a foreign body response.



    Tissue-engineered implants prevent gross, degenerative changes to the condylar head caused by disc thinning

    Gross and histological examinations of condylar surfaces were informative in determining the effectiveness of tissue-engineered implant treatment in delaying or preventing degeneration of the joint's articulating components (mandibular head and temporal articular fossa).



    Tissue-engineered implants adaptively remodel and improve integration stiffness

    Eight weeks after implantation, defects treated with tissue-engineered implants showed greater integration (fusion) between the two-disc laminae.


    The author said,"This work demonstrates that tissue-engineered implants produced from allogeneic, passaged costal chondrocytes can be applied to treat TMJ disc thinning, a condition is seen in early TMJ disorders that precede severe degenerative changes in this joint. Using an innovative surgical approach, reproducible defects modeling early-stage TMJ disc disease were treated with tissue-engineered implants."


    According to the authors, healing was more robust in the implant-treated discs compared with untreated defects, demonstrating repair of a fenestration defect modeling TMJ disc thinning. Repair tissue formed in response to treatment exhibited a greater Young's modulus than that of the repair tissue formed in untreated discs. The implants also improved closure of the pouch and fenestration defects and promoted integration with the intralaminar pouch (greater fusion between the implant and surrounding native tissue).


    The authors concluded that a major advantage of the biomimetic TMJ disc implants developed in this study is that they are completely devoid of exogenous scaffold materials. Exogenous scaffolds, such as poly(lactic acid) and poly(lactic-co-glycolic acid), are known to induce a foreign body immune response and capsule formation as well as side effects induced by the by-products of polymer degradation. The intralaminar fenestration technique used in the process of making the implant helps to secure the engineered implant to native tissues without direct sutures. Suturing tissue-engineered implants to tissue defects is a commonly used fixation method.


    Athanasiou said that the results might also apply to the treatment of hip, knee and other problem areas. The animals that did not receive the cartilage implants saw a 300 percent increase in osteoarthritis, which many TMJ patients eventually develop, while the treated ones did not.


    For more reference log on to

    http://stm.sciencemag.org/content/10/446/eaaq1802.full
    capsule formationcondylar headdirect suturesexogenous scaffoldimmunoreactivityimplant breakage or fragmentationintralaminar fenestration techniqueintralaminar pouchKyriacos Athanasiouosteoarthritispolymer degradationScience Translational Medicinetissue engineered implantsTMJ disc implantsUC researchers
    Source : With inputs from the journal Science Translational Medicine

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Vinay Singh singh
    Vinay Singh singh
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 12 Oct 2022 7:06 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok